Dr Emma Spurrell, Consultant Medical Oncologist
Dr Emma Spurrell
Consultant Medical Oncologist
Dr Emma Spurrell PhD FRCP
Consultant Medical Oncologist
Dr Emma Spurrell
Consultant Medical Oncologist PhD FRCP
Dr Spurrell is a Consultant Medical Oncologist
Make an appointment
Address
-
The Harley Street Clinic
35 Weymouth Street, London, W1G 8BJ
-
LOC - Leaders in Oncology Care
95 Harley Street, London, W1G 6AF
About Dr Emma Spurrell
GMC number: 4600617
Year qualified: 1999
Place of primary qualification: University of London
Dr Emma Spurrell is a highly regarded consultant medical oncologist with a special interest in breast cancer. She has been practising at the Leaders in Oncology Care since her appointment in 2013. Dr Spurrell completed her specialist training in medical oncology at St Bartholomew's Medical School, where she also gained an MRC clinical research training fellowship and completed her PhD in gene therapy.
Dr Spurrell's areas of expertise include the treatment and management of breast cancer, with a focus on personalised medicine and advanced therapeutic techniques. She is proficient in a range of procedures, including chemotherapy, targeted therapy, and immunotherapy. Her clinical interests also extend to the development of new treatment protocols and the integration of cutting-edge research into clinical practice.
In her role, Dr Spurrell is dedicated to providing comprehensive care to her patients, ensuring they receive the most effective and up-to-date treatments available. She is known for her compassionate approach and commitment to improving patient outcomes. Dr Spurrell continues to contribute to the field of oncology through her involvement in clinical trials and research initiatives aimed at advancing cancer treatment.
Professional memberships
Articles by Dr Emma Spurrell
Cardiovascular Disease Amongst Women Treated for Breast Cancer: Traditional Cytotoxic Chemotherapy, Targeted Therapy, and Radiation Therapy.
Adjuvant Chemotherapy for Breast Cancer in Older Women.
A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast Cancer.
The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience.
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19.
Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital.
Adaptive immunity in cancer immunology and therapeutics.
A Case of Ovarian Fibromatosis and Massive Ovarian Oedema Associated With Intra-Abdominal Fibromatosis, Sclerosing Peritonitis and Meig's Syndrome.
STAT1 interaction with E3-14.7K in monocytes affects the efficacy of oncolytic adenovirus.
